Rain(2) | $58,000,000 | (Aug 29, 2025)
ALIGNMT AI | $6,500,000 | (Aug 29, 2025)
Matey AI | $7,500,000 | (Aug 29, 2025)
Certified by Founder
Lodge
Zura Bio Limited
start up
United States
- San Diego, CA
- 07/06/2023
- Unknown
- $80,000,000
Zura Bio Limited is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab. ZB-168 is an anti IL7R α inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Zura aims to develop a portfolio of therapeutic indications for ZB-168 which build on existing Phase 1b data in Type 1 Diabetes demonstrating a favorable safety profile and strong biological rationale. Torudokimab is a fully human, high affinity monoclonal antibody that neutralizes IL33 and is currently at the Phase 2 clinical development stage. Zura Bio is headquartered in San Diego, CA with team members in the UK and USA.
- Industry Biotechnology Research
- Website https://zurabio.com/
- LinkedIn https://www.linkedin.com/company/zura-bio-limited/
Related People
Someit SidhuFounder
United Kingdom -
London, England
N/A
LinkedIn
https://www.linkedin.com/in/someit/
Ordinal | $1,000,000 | (Aug 29, 2025)
Cumin Co. | $1,500,000 | (Aug 29, 2025)
Nuyug | $285,129 | (Aug 29, 2025)
Maisa | $25,000,000 | (Aug 29, 2025)
Copper | $28,000,000 | (Aug 29, 2025)
PALMONAS | $6,269,923 | (Aug 29, 2025)
Sola(US) | $8,000,000 | (Aug 29, 2025)
Mantic | $4,000,000 | (Aug 29, 2025)
M0 | $40,000,000 | (Aug 29, 2025)